DiscoverRessources
Publications
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification
Discover
Publications
Targeting genome integrity dysfunctions impedes metastatic potency in non-small-cell lung cancer circulating tumor cellderived eXplants
CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.
Discover
Publications
STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021
Discover
Publications
Paediatric Liver Cancer
A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy
Discover
news
XenTech remains fully operational after 7 weeks of COVID-19 pandemic : update from our COO
In this 7th week of containment and as end of confinement in France is announced for May 11th, I would first of all like to thank you on behalf of our teams for all the messages of support you have sent us since the beginning of the COVID-19 crisis.
Discover
news
XenTech Covid-19 management
Regarding the current circumstances, we at XenTech want you to know that we are taking the Covid-19 pandemia very seriously. We are closely monitoring the pandemic, following guidance and advice from the World Health Organization (WHO), and the French Government.
Discover
publications
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification
Discover
publications
Targeting genome integrity dysfunctions impedes metastatic potency in non-small-cell lung cancer circulating tumor cellderived eXplants
CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.
Discover
publications
STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021
Discover
publications
Paediatric Liver Cancer
A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy
Discover
01Conferences & events
06.20.22
XenTech exhibits at EACR 2022 (Seville, Jun. 20-23 2022)
We'll be exhibiting at EACR in Seville, stop by booth #50 !
Discover
04.08.22
XenTech exhibits at AACR Annual Meeting (New Orleans, Apr.8-13 2022)
We'll be exhibiting at AACR New Orleans from Apr.8th 2022, stop by our booth to chat with us (at last!)
Discover
10.05.21
XenTech live at AACR Spotlight Series
Discover
10.25.21
XenTech will attend BIO-EUROPE
Discover
